305 related articles for article (PubMed ID: 33918297)
1. Comprehensive Profiling of Secretome Formulations from Fetal- and Perinatal Human Amniotic Fluid Stem Cells.
Costa A; Ceresa D; De Palma A; Rossi R; Turturo S; Santamaria S; Balbi C; Villa F; Reverberi D; Cortese K; De Biasio P; Paladini D; Coviello D; Ravera S; Malatesta P; Mauri P; Quarto R; Bollini S
Int J Mol Sci; 2021 Apr; 22(7):. PubMed ID: 33918297
[TBL] [Abstract][Full Text] [Related]
2. First Characterization of Human Amniotic Fluid Stem Cell Extracellular Vesicles as a Powerful Paracrine Tool Endowed with Regenerative Potential.
Balbi C; Piccoli M; Barile L; Papait A; Armirotti A; Principi E; Reverberi D; Pascucci L; Becherini P; Varesio L; Mogni M; Coviello D; Bandiera T; Pozzobon M; Cancedda R; Bollini S
Stem Cells Transl Med; 2017 May; 6(5):1340-1355. PubMed ID: 28271621
[TBL] [Abstract][Full Text] [Related]
3. Reactivating endogenous mechanisms of cardiac regeneration via paracrine boosting using the human amniotic fluid stem cell secretome.
Balbi C; Lodder K; Costa A; Moimas S; Moccia F; van Herwaarden T; Rosti V; Campagnoli F; Palmeri A; De Biasio P; Santini F; Giacca M; Goumans MJ; Barile L; Smits AM; Bollini S
Int J Cardiol; 2019 Jul; 287():87-95. PubMed ID: 30987834
[TBL] [Abstract][Full Text] [Related]
4. Investigating the Paracrine Role of Perinatal Derivatives: Human Amniotic Fluid Stem Cell-Extracellular Vesicles Show Promising Transient Potential for Cardiomyocyte Renewal.
Costa A; Balbi C; Garbati P; Palamà MEF; Reverberi D; De Palma A; Rossi R; Paladini D; Coviello D; De Biasio P; Ceresa D; Malatesta P; Mauri P; Quarto R; Gentili C; Barile L; Bollini S
Front Bioeng Biotechnol; 2022; 10():902038. PubMed ID: 35757808
[TBL] [Abstract][Full Text] [Related]
5. The human amniotic fluid stem cell secretome triggers intracellular Ca
Balducci V; Faris P; Balbi C; Costa A; Negri S; Rosti V; Bollini S; Moccia F
J Cell Mol Med; 2021 Aug; 25(16):8074-8086. PubMed ID: 34288391
[TBL] [Abstract][Full Text] [Related]
6. Fetal and perinatal stem cells in cardiac regeneration: Moving forward to the paracrine era.
Balbi C; Bollini S
Placenta; 2017 Nov; 59():96-106. PubMed ID: 28416208
[TBL] [Abstract][Full Text] [Related]
7. Extracellular vesicles from II trimester human amniotic fluid as paracrine conveyors counteracting oxidative stress.
Giorgia S; Laura G; Maddalena G; Nadia B; Stefano R; Nicole G; Martina B; Ambra C; Andrea R; Cristina G; Sara B; Valentina M; Dario P; Domenico C; Assunta P; Benedetta B; Andrea P; Grazia F; Silvia R; Lucio B; Carolina B; Sveva B
Redox Biol; 2024 Jun; 75():103241. PubMed ID: 38901103
[TBL] [Abstract][Full Text] [Related]
8. The Human Fetal and Adult Stem Cell Secretome Can Exert Cardioprotective Paracrine Effects against Cardiotoxicity and Oxidative Stress from Cancer Treatment.
Villa F; Bruno S; Costa A; Li M; Russo M; Cimino J; Altieri P; Ruggeri C; Gorgun C; De Biasio P; Paladini D; Coviello D; Quarto R; Ameri P; Ghigo A; Ravera S; Tasso R; Bollini S
Cancers (Basel); 2021 Jul; 13(15):. PubMed ID: 34359631
[TBL] [Abstract][Full Text] [Related]
9. The human amniotic fluid stem cell secretome effectively counteracts doxorubicin-induced cardiotoxicity.
Lazzarini E; Balbi C; Altieri P; Pfeffer U; Gambini E; Canepa M; Varesio L; Bosco MC; Coviello D; Pompilio G; Brunelli C; Cancedda R; Ameri P; Bollini S
Sci Rep; 2016 Jul; 6():29994. PubMed ID: 27444332
[TBL] [Abstract][Full Text] [Related]
10. Small Extracellular Vesicles from Human Amniotic Fluid Samples as Promising Theranostics.
Costa A; Quarto R; Bollini S
Int J Mol Sci; 2022 Jan; 23(2):. PubMed ID: 35054775
[TBL] [Abstract][Full Text] [Related]
11. Human amniotic fluid stem cells have a unique potential to accelerate cutaneous wound healing with reduced fibrotic scarring like a fetus.
Fukutake M; Ochiai D; Masuda H; Abe Y; Sato Y; Otani T; Sakai S; Aramaki-Hattori N; Shimoda M; Matsumoto T; Miyakoshi K; Kanai Y; Kishi K; Tanaka M
Hum Cell; 2019 Jan; 32(1):51-63. PubMed ID: 30506493
[TBL] [Abstract][Full Text] [Related]
12. Amniotic fluid stem cells are cardioprotective following acute myocardial infarction.
Bollini S; Cheung KK; Riegler J; Dong X; Smart N; Ghionzoli M; Loukogeorgakis SP; Maghsoudlou P; Dubé KN; Riley PR; Lythgoe MF; De Coppi P
Stem Cells Dev; 2011 Nov; 20(11):1985-94. PubMed ID: 21534857
[TBL] [Abstract][Full Text] [Related]
13. Comparison of EV-free fraction, EVs, and total secretome of amniotic mesenchymal stromal cells for their immunomodulatory potential: a translational perspective.
Papait A; Ragni E; Cargnoni A; Vertua E; Romele P; Masserdotti A; Perucca Orfei C; Signoroni PB; Magatti M; Silini AR; De Girolamo L; Parolini O
Front Immunol; 2022; 13():960909. PubMed ID: 36052081
[TBL] [Abstract][Full Text] [Related]
14. A novel method to derive amniotic fluid stem cells for therapeutic purposes.
Phermthai T; Odglun Y; Julavijitphong S; Titapant V; Chuenwattana P; Vantanasiri C; Pattanapanyasat K
BMC Cell Biol; 2010 Oct; 11():79. PubMed ID: 20955626
[TBL] [Abstract][Full Text] [Related]
15. Human amniotic fluid stem cell preconditioning improves their regenerative potential.
Rota C; Imberti B; Pozzobon M; Piccoli M; De Coppi P; Atala A; Gagliardini E; Xinaris C; Benedetti V; Fabricio AS; Squarcina E; Abbate M; Benigni A; Remuzzi G; Morigi M
Stem Cells Dev; 2012 Jul; 21(11):1911-23. PubMed ID: 22066606
[TBL] [Abstract][Full Text] [Related]
16. Amniotic fluid derived stem cells promote skin regeneration and alleviate scar formation through exosomal miRNA-146a-5p via targeting CXCR4.
Wgealla MMAMA; Liang H; Chen R; Xie Y; Li F; Qin M; Zhang X
J Cosmet Dermatol; 2022 Oct; 21(10):5026-5036. PubMed ID: 35364624
[TBL] [Abstract][Full Text] [Related]
17. The neurorestorative effect of human amniotic fluid stem cells on the chronic phase of neonatal hypoxic-ischemic encephalopathy in mice.
Otani T; Ochiai D; Masuda H; Abe Y; Fukutake M; Matsumoto T; Miyakoshi K; Tanaka M
Pediatr Res; 2019 Jan; 85(1):97-104. PubMed ID: 30120407
[TBL] [Abstract][Full Text] [Related]
18. Supporting data on in vitro cardioprotective and proliferative paracrine effects by the human amniotic fluid stem cell secretome.
Balbi C; Lodder K; Costa A; Moimas S; Moccia F; van Herwaarden T; Rosti V; Campagnoli F; Palmeri A; De Biasio P; Santini F; Giacca M; Goumans MJ; Barile L; Smits AM; Bollini S
Data Brief; 2019 Aug; 25():104324. PubMed ID: 31453298
[TBL] [Abstract][Full Text] [Related]
19. Human amniotic fluid stem cells protect rat lungs exposed to moderate hyperoxia.
Grisafi D; Pozzobon M; Dedja A; Vanzo V; Tomanin R; Porzionato A; Macchi V; Salmaso R; Scarpa M; Cozzi E; Fassina A; Navaglia F; Maran C; Onisto M; Caenazzo L; De Coppi P; De Caro R; Chiandetti L; Zaramella P
Pediatr Pulmonol; 2013 Nov; 48(11):1070-80. PubMed ID: 23533160
[TBL] [Abstract][Full Text] [Related]
20. Amniotic fluid stem cell exosomes: Therapeutic perspective.
Beretti F; Zavatti M; Casciaro F; Comitini G; Franchi F; Barbieri V; La Sala GB; Maraldi T
Biofactors; 2018 Mar; 44(2):158-167. PubMed ID: 29341292
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
